Scholars Central

Conference abstractPublished 18 Jul 2018

Sigma-2 (σ2) receptor ligands as potential anticancer agents for pancreatic cancer

Authors: Lamya Alghanim

Florida Agricultural and Mechanical University, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pancreatic cancer is the fourth leading cause of cancer-related mortality amongst all cancers. The overall 5-year survival rate is 6% and the total cost of treatment is estimated to be 4.9 billion dollars per year in the United States. One major obstacle in the treatment of cancer is the development of selective chemotherapeutic agents. Sigma receptors, particularly the sigma-2 subtype, have emerged as an interesting target for the design of treatments for various cancers. They are overexpressed in rapidly proliferating cancer cells. Hence, sigma-2 receptor ligands may represent a platform for chemotherapeutics of pancreatic and other types of cancers. We recently synthesized a series of modified compounds and determined their affinity to various receptors. Binding studies show that compound 23 favorably interacts with sigma-2 receptors (Ki = 2.7 nM). Evaluation of the cytotoxic effects of these compounds on various pancreatic cancer cell lines is ongoing.

Subjects

Chemistry

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Organic Chemistry: Current Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalOrganic Chemistry: Current Research
  • SubjectChemistry
  • BylineArticles whose byline prints “Lamya Alghanim”